Amoxicillin Resistance Test · Stool

Helicobacter pylori (H. pylori for short) is one of the most common stomach infections in the world, and the standard cure relies on a two-week course of antibiotics that almost always includes amoxicillin. The whole regimen hinges on amoxicillin actually working.

If the H. pylori strain in your stomach carries genes that let it shrug off amoxicillin, that two-week course can fail entirely, leaving the infection in place and giving the bacteria more time to drive ulcers, chronic inflammation, and stomach cancer risk. This stool-based test reads the resistance genes directly so you can find that out before treatment, not after it fails.

Why Amoxicillin Resistance Matters for Treatment

Amoxicillin is a cornerstone of nearly every first-line H. pylori regimen, including bismuth quadruple therapy and the newer vonoprazan-amoxicillin dual therapy. When a strain carries resistance, these regimens lose much of their power.

A pooled analysis of five randomized trials found that amoxicillin resistance increased the risk of eradication failure across regimens, with the breakpoint above which failure became more likely set at a very low concentration of the drug. In plain terms, even modest resistance was enough to tip a treatment from likely cure to likely failure.

A separate large study of more than 1,000 people whose first H. pylori treatment had failed showed that switching to a regimen guided by the strain's resistance profile produced higher cure rates than blindly trying another empirical course. Knowing your resistance status up front is how you skip that costly first failure.

How H. pylori Becomes Resistant

Amoxicillin works by binding to a bacterial protein that builds the cell wall, called penicillin-binding protein 1A. If the gene that codes for this protein, known as pbp1A, picks up specific point mutations, the protein changes shape just enough that amoxicillin can no longer lock on. The bacteria keep building their wall, and the antibiotic loses its grip.

A study of 308 people in Vietnam found several specific amino acid substitutions in pbp1A that were strongly enriched in amoxicillin-resistant strains, including novel mutations not previously described. These genetic fingerprints are what stool-based resistance assays look for.

Resistance Rates Vary Widely by Region

How likely your strain is to be resistant depends heavily on where it came from. Antibiotic exposure patterns in the surrounding population shape the local pool of H. pylori, and that pool can look very different from country to country.

A meta-analysis of regions across China found primary amoxicillin resistance in roughly 3% of strains, low enough that standard amoxicillin-based regimens still work for most people. The Vietnam study, by contrast, found resistance in 25.7% of treatment-naive patients, meaning roughly one in four people would head into standard therapy with a strain primed to survive it. World Health Organization regional data show this same kind of wide variation across continents.

Result Interpretation

This test is qualitative. It looks for known resistance gene mutations and reports whether they were found, not the share of resistant bacteria in your stomach. Results should always be read alongside a separate test confirming H. pylori is actually present.

Compare your result within the same lab over time, since assays differ in which mutations they screen for and how they report them.

What to Do With a Positive Result

A positive amoxicillin resistance result on its own is not a treatment plan. It is a signal that the standard playbook needs to change. Pair this finding with the rest of the H. pylori workup: confirmation of active infection, and resistance testing for the other antibiotics commonly used in eradication regimens, such as clarithromycin, fluoroquinolones, and tetracycline.

If amoxicillin resistance is detected alongside resistance to clarithromycin, you are looking at a strain that is unlikely to respond to either of the two most common first-line regimens. That pattern is worth bringing to a gastroenterologist who can build a salvage regimen, often with bismuth and combinations of less commonly used antibiotics, based on what the strain still responds to.

Tracking Your Result

The most useful time to test is before any treatment, when the resistance pattern of your untouched strain is clearest. A second test, at least four weeks after finishing therapy and after stopping any acid blockers for two weeks, confirms whether the bacteria, and their resistance genes, are gone.

If a treatment fails, test again before the next attempt. The strain that survived the first round is the one you are now fighting, and it may have a different or expanded resistance profile than the one you started with. Antibiotic regimens themselves can quickly select for new resistance, so a fresh read before round two is more useful than relying on the original result.

When Results Can Be Misleading

• Recent antibiotic use: taking any antibiotics in the four weeks before testing can lower the bacterial load below what the test can detect, producing a false negative for both H. pylori and its resistance genes.
• Acid-suppressing medications: proton pump inhibitors and similar drugs reduce H. pylori shedding into stool. Stopping these for at least two weeks before testing is standard practice for any stool-based H. pylori workup.
• Sample-related issues: delays in stool transport, contamination, or low DNA yield can all affect whether the assay can pick up the gene reliably. A negative result in a sample that was hard to process should be repeated.
• Mixed strains: some people carry more than one H. pylori strain. The test reports whether resistance was detected at all, so a single resistant strain in a mixed population still flags positive, even if most of your bacteria are sensitive.